Physiomics Plc announce that it has been awarded its first contract with a new UK-based biotech client. The contract, which has a value of £125,000 and relates to a project in the immune-oncology field, is expected to be completed within this calendar year.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.25 GBX | 0.00% | 0.00% | -21.88% |
May. 03 | Physiomics warns large contracts taken longer than expected | AN |
May. 03 | AIM WINNERS & LOSERS: Fletcher King optimistic; Angle in Astra deal | AN |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.88% | 2.15M | |
-0.15% | 137B | |
+21.93% | 77.04B | |
-10.63% | 40.58B | |
+14.34% | 38.07B | |
-5.68% | 17.25B | |
+11.51% | 15.32B | |
+9.51% | 10.44B | |
-10.60% | 4.71B | |
-34.99% | 3.96B |
- Stock Market
- Equities
- PYC Stock
- News Physiomics Plc
- Physiomics plc Wins Further Contract by Uk-Based Biotech Client